Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Windlas Biotech Ltd

Pharmaceuticals & Biotechnology | Small Cap

Windlas Biotech Ltd Health Insights
Health Score : 7.52Health Score : 7.52

Windlas Biotech demonstrates a mixed financial performance. The company shows strong solvency, growth, coverage, and profitability. It maintains a very low level of debt and robust growth in revenue, operating profit, and earnings per share, alongside excellent interest and dividend coverage. Profitability metrics such as gross profit margin, ROCE, ROE, ROA, and operating and net margins are also very strong. However, there are concerns regarding liquidity and efficiency. The company's liquidity ratios suggest challenges in meeting short-term obligations, while efficiency ratios indicate potential issues with asset utilization, particularly in fixed assets and capital turnover. Financial ratios also present some weaknesses. Overall, Windlas Biotech exhibits solid financial health driven by growth and profitability, but needs to address areas related to liquidity and efficiency to ensure long-term stability and performance.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Windlas Biotech Ltd Health Insights
Health Score : 7.52Health Score : 7.52

Windlas Biotech demonstrates a mixed financial performance. The company shows strong solvency, growth, coverage, and profitability. It maintains a very low level of debt and robust growth in revenue, operating profit, and earnings per share, alongside excellent interest and dividend coverage. Profitability metrics such as gross profit margin, ROCE, ROE, ROA, and operating and net margins are also very strong. However, there are concerns regarding liquidity and efficiency. The company's liquidity ratios suggest challenges in meeting short-term obligations, while efficiency ratios indicate potential issues with asset utilization, particularly in fixed assets and capital turnover. Financial ratios also present some weaknesses. Overall, Windlas Biotech exhibits solid financial health driven by growth and profitability, but needs to address areas related to liquidity and efficiency to ensure long-term stability and performance.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

25.35

Neutral

Industry Median

28.62

Neutral
Neutral

Small Cap Median

27.17

Neutral

P/E RATIO

25.92

P/B RATIO

2.97

Neutral

Industry Median

3.17

Neutral
Neutral

Small Cap Median

2.62

Neutral

P/S RATIO

1.83

Undervalued

Industry Median

3.42

Undervalued
Undervalued

Small Cap Median

2.55

Undervalued

Others

Neutral

PEG RATIO

0.00

Neutral
Overvalued

EV/EBITDA RATIO

13.49

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹816 as on Jun 21, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company exhibits excellent growth across all key metrics. Strong revenue growth, operating profit growth, EPS growth, asset growth, and net income growth reflect robust business expansion and effective management strategies. This indicates a positive trajectory and strong potential for future performance. The company is effectively scaling its operations and profitability.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate8.8810.092320.4418.95
Operating Profit Growth Rate-3.6413.213020.5111.7
Earnings Per Share (EPS) Growth126.513.3439.43.548.78
Asset Growth Rate65.887.7418.3421.4119.34
Net Income Growth Rate68010.2634.885.178.2
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 5.00

The financial metrics present a mixed view. While the dividend per share is well-managed, the adjusted EPS, cash EPS, and book value per share suggest areas needing attention. The high capital expenditures indicate significant investments, but their returns are not yet fully reflected in the earnings. The company should focus on optimizing its investments and improving earnings quality. The long-term sustainability of these investments needs careful evaluation.

AverageAdjusted Earnings Per Share (Adjusted EPS)Average
WeakCash Earnings Per Share (Cash EPS)Weak
WeakBook Value Per ShareWeak
GoodDividend Per Share (DPS)Good
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)17.73212930.530
Cash Earnings Per Share (Cash EPS)23.1827.535.544.544.09
Book Value Per Share179.55201225252.5264.09
Dividend Per Share (DPS)3.544.015.595.796.3
Capital Expenditures (CapEx)1570385268
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company exhibits excellent profitability across all key metrics. Strong gross profit margin, ROCE, ROE, ROA, operating margin, and net margin reflect effective cost management and operational efficiency. This indicates a highly profitable and well-managed business. The company is generating substantial returns on its investments and assets.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin8.89.3610.38.688.19
Return on Capital Employed (ROCE)1514181716
Return on Equity (ROE)9.8710.712.8912.0811.36
Return on Assets (ROA)10.7911.3412.4612.3711.58
Operating Margin11.3711.712.3612.3711.62
Net Margin8.378.389.198.037.3
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 4.67

The efficiency metrics reveal a mixed performance. While the inventory turnover and days sales in inventory are reasonably managed, the fixed asset turnover, receivables turnover, receivable days, and capital turnover ratios indicate potential areas of concern. The company could improve asset utilization and management of receivables to enhance overall efficiency. There is a need to optimize the use of fixed assets and improve the collection of receivables to boost operational effectiveness.

WeakFixed Asset Turnover RatioWeak
GoodInventory Turnover RatioGood
WeakReceivables Turnover RatioWeak
GoodDays Sales in Inventory RatioGood
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio5.124.713.533.414.17
Inventory Turnover Ratio8.56.948.269.7111.61
Receivables Turnover Ratio4.914.54.995.024.59
Days Sales in Inventory Ratio42.9452.5944.1937.5931.44
Receivable Days74.3481.1173.1572.7179.52
Capital Turnover Ratio1.181.261.391.491.54
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 10.00

The company demonstrates excellent coverage ratios. The high-interest coverage ratio indicates a strong ability to meet its interest obligations. The equity dividend coverage ratio shows a strong ability to cover dividend payments. This reflects a solid financial cushion for both debt and equity holders. The company is well-positioned to manage its financial obligations effectively.

ExcellentInterest Coverage RatioExcellent
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio47587820.7518.4
Equity Dividend Coverage Ratio55555
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits excellent solvency. The very low debt ratio and debt-to-equity ratio, combined with a high equity ratio and debt to asset ratio, indicate a strong financial position with minimal reliance on debt. This provides financial stability and reduces the risk of financial distress. This signifies a very conservative approach to leverage, which can support long-term sustainability.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio00.010.010.010.01
Debt to Equity Ratio00.010.010.010.01
Equity Ratio10.990.990.990.99
Debt To Asset Ratio00.010.010.010.01
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 5.86

The liquidity position reflects a mixed outlook. While the quick ratio suggests a reasonable ability to meet short-term obligations, the lower cash and operating cash flow ratios indicate potential challenges in immediate cash availability and operational cash generation. Though the current ratio is at an average level, the company might face difficulties in efficiently managing its current assets to cover its current liabilities, which may affect day to day operations.

AverageCurrent RatioAverage
GoodQuick RatioGood
WeakCash RatioWeak
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio3.452.461.561.241.14
Quick Ratio2.831.841.20.910.95
Cash Ratio1.20.210.180.060.01
Operating Cash Flow Ratio0.10.50.630.270.33
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 20 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Jagsonpal Pharmaceuticals Ltd8.5133.01Overvalued58.006.4243.00
2Amrutanjan Health Care Ltd8.2577.37Highly Overvalued31.0020.0321.00
3Accent Microcell Ltd7.9624.25Neutral57.0018.2844.00
4Windlas Biotech Ltd7.5225.92Neutral105.0032.1966.00
5Lincoln Pharmaceuticals Ltd7.3114.01Neutral98.0043.8888.00
6Morepen Laboratories Ltd7.1228.61Neutral126.001.2196.00
7Alembic Ltd7.067.28Undervalued90.004.85317.00
8NGL Fine Chem Ltd6.9839.22Overvalued73.0067.3948.00
9Syncom Formulations (India) Ltd6.9217.27Undervalued77.000.8176.00
10Hester Biosciences Ltd6.5431.74Neutral87.0061.2457.00
11Sigachi Industries Ltd6.4911.55Highly Undervalued54.00-2.08-83.00
12Sakar Healthcare Ltd5.8158.66Highly Overvalued69.0013.7030.00
13Remus Pharmaceuticals Ltd5.3125.48Neutral57.0020.9746.00
14IOL Chemicals & Pharmaceuticals Ltd5.3127.76Undervalued269.004.69138.00
15Indoco Remedies Ltd5.26-22.79Neutral142.00-0.61-99.00
16Ind-Swift Laboratories Ltd4.9539.28Neutral45.004.8941.00
17Venus Remedies Ltd4.8323.37Neutral147.0074.30103.00
18Wanbury Ltd4.6528.62Neutral88.0018.9343.00
19Solara Active Pharma Sciences Ltd4.34-274.68Neutral187.00-1.50-7.00
Management Assessment Summary
OrangeBalanced Management

Windlas Biotech demonstrates mixed management effectiveness. Revenue expansion is robust, with consistent sales growth. However, profit growth is volatile and slowing down, and there's a noticeable increase in borrowings in the most recent year. Overall, the company demonstrates strengths in revenue generation and operational efficiency, but profit volatility and increased debt raise concerns about financial management.

Category Metric Value Assessment
PROS Sales Growth (2025) 20.43% Strong ability to expand its revenue base.
Promoter Holding (Mar 2025) 62.34% Promoters' confidence in the company's future performance.
CONS Profit Growth (2025) 5.17% Inconsistent and shows signs of slowing down.
Borrowings (2025) ₹ 32.57 Cr Increase in debt could elevate financial risk and interest expenses.
AverageFinancial Performance & GrowthAverage
GoodCapital Efficiency & ReturnsGood
AverageFinancial Health & PrudenceAverage
ExcellentShareholding & Ownership StructureExcellent
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

Windlas Biotech faces moderate risk due to segment performance volatility and increasing debt. Sales growth is robust, but profit growth is inconsistent. The company's reliance on specific segments and increased borrowings raise concerns. While promoter holding remains strong, the overall risk profile is considered moderate, requiring vigilance in managing financial leverage and operational stability.

AverageSegment performance volatilityAverage
AverageForeign exchange or interest rate exposureAverage
AverageRegulatory compliance cost trendsAverage
01.

Segment performance volatility

02.

Foreign exchange or interest rate exposure

03.

Regulatory compliance cost trends

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10815.47Bullish
  3. SMA 20815.21Bullish
  4. SMA 50816.61Bearish
  5. EMA 10816.34Bearish
  6. EMA 20816.07Bearish
  7. EMA 50816.44Bearish
  8. DEMA 10817.27Bearish
  9. DEMA 20815.75Bullish
  10. DEMA 50816.97Bearish
  11. TEMA 10818.14Bearish
  12. TEMA 20816.41Bearish
  13. TEMA 50814.98Bullish
  14. MACD-0.03Bullish
  15. ADX23.50Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI49.69Neutral
  3. CCI-17.35Neutral
  4. ROC 91.25Bullish
  5. ROC 140.62Bullish
  6. ROC 25N/ABearish
  7. Stoch K50.22Neutral
  8. Stoch D56.13Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper826.05Neutral
  3. BB Middle815.21Neutral
  4. BB Lower804.37Neutral
  5. ATR9.13Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI46.83Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10814.26Bullish
  3. SMA 20816.95Bearish
  4. SMA 50816.84Bearish
  5. EMA 10815.92Bullish
  6. EMA 20816.40Bearish
  7. EMA 50815.43Bullish
  8. DEMA 10815.70Bullish
  9. DEMA 20815.73Bullish
  10. DEMA 50818.33Bearish
  11. TEMA 10816.49Bearish
  12. TEMA 20814.67Bullish
  13. TEMA 50818.92Bearish
  14. MACD-0.50Bullish
  15. ADX20.03Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI49.59Neutral
  3. CCI-60.23Neutral
  4. ROC 9-0.81Bearish
  5. ROC 14-1.04Bearish
  6. ROC 250.87Bullish
  7. Stoch K40.61Neutral
  8. Stoch D42.28Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper827.71Neutral
  3. BB Middle816.95Neutral
  4. BB Lower806.19Neutral
  5. ATR12.85Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI40.43Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10816.85Bearish
  3. SMA 20817.67Bearish
  4. SMA 50805.50Bullish
  5. EMA 10815.97Bullish
  6. EMA 20815.59Bullish
  7. EMA 50812.08Bullish
  8. DEMA 10815.24Bullish
  9. DEMA 20817.78Bearish
  10. DEMA 50815.03Bullish
  11. TEMA 10814.18Bullish
  12. TEMA 20816.69Bearish
  13. TEMA 50N/AN/A
  14. MACD1.21Bearish
  15. ADX26.15Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI50.63Neutral
  3. CCI1.09Neutral
  4. ROC 9-0.55Bearish
  5. ROC 14-0.23Bearish
  6. ROC 251.08Bullish
  7. Stoch K33.68Neutral
  8. Stoch D23.20Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper833.81Neutral
  3. BB Middle817.67Neutral
  4. BB Lower801.52Neutral
  5. ATR20.03Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI72.71Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10819.39Bearish
  3. SMA 20815.07Bullish
  4. SMA 50823.90Bearish
  5. SMA 100800.86Bullish
  6. SMA 200834.96Bearish
  7. EMA 10816.70Bearish
  8. EMA 20815.15Bullish
  9. EMA 50811.34Bullish
  10. EMA 100812.24Bullish
  11. EMA 200830.42Bearish
  12. DEMA 10817.90Bearish
  13. DEMA 20817.40Bearish
  14. DEMA 50817.01Bearish
  15. DEMA 100798.54Bullish
  16. DEMA 200802.61Bullish
  17. TEMA 10816.24Bearish
  18. TEMA 20818.35Bearish
  19. TEMA 50821.92Bearish
  20. TEMA 100815.26Bullish
  21. TEMA 200766.46Bullish
  22. MACD1.89Bullish
  23. ADX16.18Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI50.58Neutral
  3. CCI12.23Neutral
  4. ROC 140.36Bullish
  5. ROC 257.04Bullish
  6. Stoch K37.09Neutral
  7. Stoch D43.70Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper838.94Neutral
  3. BB Middle815.07Neutral
  4. BB Lower791.19Neutral
  5. ATR28.94Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI45.77Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20799.61Bullish
  3. SMA 50854.65Bearish
  4. EMA 20811.63Bullish
  5. EMA 50834.17Bearish
  6. DEMA 20801.69Bullish
  7. DEMA 50818.58Bullish
  8. TEMA 20819.21Bullish
  9. TEMA 50763.82Bullish
  10. MACD-4.58Bullish
  11. ADX12.51Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI49.54Neutral
  3. CCI-33.02Neutral
  4. ROC 1410.89Bullish
  5. ROC 255.99Bullish
  6. Stoch K62.79Neutral
  7. Stoch D57.08Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper885.45Neutral
  3. BB Middle799.61Neutral
  4. BB Lower713.76Neutral
  5. ATR68.05Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI68.82Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6803.44Bullish
  3. SMA 12861.15Bearish
  4. SMA 24893.07Bearish
  5. EMA 6822.56Bullish
  6. EMA 12839.45Bearish
  7. EMA 24804.75Bullish
  8. DEMA 6805.58Bullish
  9. DEMA 12831.06Bullish
  10. DEMA 24941.33Bearish
  11. TEMA 6815.64Bullish
  12. TEMA 12779.83Bullish
  13. TEMA 24N/AN/A
  14. MACD226.82Bearish
  15. ADX34.39Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI54.87Neutral
  3. CCI52.77Neutral
  4. ROC 2550.72Bullish
  5. ROC 50296.62Bullish
  6. Stoch K52.36Neutral
  7. Stoch D71.01Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1135.40Neutral
  3. BB Middle911.69Neutral
  4. BB Lower687.98Neutral
  5. ATR159.77Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI46.74Neutral